Rob Zuiker

1.2k total citations
51 papers, 866 citations indexed

About

Rob Zuiker is a scholar working on Experimental and Cognitive Psychology, Cognitive Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Rob Zuiker has authored 51 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Experimental and Cognitive Psychology, 19 papers in Cognitive Neuroscience and 12 papers in Endocrine and Autonomic Systems. Recurrent topics in Rob Zuiker's work include Sleep and related disorders (16 papers), Sleep and Wakefulness Research (15 papers) and Circadian rhythm and melatonin (10 papers). Rob Zuiker is often cited by papers focused on Sleep and related disorders (16 papers), Sleep and Wakefulness Research (15 papers) and Circadian rhythm and melatonin (10 papers). Rob Zuiker collaborates with scholars based in Netherlands, United States and Switzerland. Rob Zuiker's co-authors include Joop van Gerven, Jasper Dingemanse, Clemens Muehlan, Gabriël E. Jacobs, Wayne C. Drevets, Zuzana Diamant, Peter van der Ark, Dave Singh, Adam F. Cohen and Luc Van Nueten and has published in prestigious journals such as PLoS ONE, Neurology and Experimental Brain Research.

In The Last Decade

Rob Zuiker

50 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob Zuiker Netherlands	16	295	286	216	213	153	51	866
Laurène Leclair‐Visonneau France	20	317 1.1×	162 0.6×	131 0.6×	360 1.7×	81 0.5×	45	1.6k
Zhuanhong Qiao United States	19	170 0.6×	191 0.7×	349 1.6×	613 2.9×	82 0.5×	29	1.1k
David D. Xiong United States	10	213 0.7×	122 0.4×	261 1.2×	221 1.0×	17 0.1×	25	768
Vahid Hajali Iran	13	187 0.6×	93 0.3×	119 0.6×	122 0.6×	25 0.2×	31	601
Zhongxin Zhao China	20	337 1.1×	250 0.9×	154 0.7×	195 0.9×	11 0.1×	44	893
Paulo J.F. Martins Brazil	13	343 1.2×	239 0.8×	365 1.7×	255 1.2×	20 0.1×	16	872
Tammy A. Butterick United States	17	301 1.0×	191 0.7×	304 1.4×	183 0.9×	11 0.1×	45	881
Masoumeh Kourosh‐Arami Iran	16	153 0.5×	80 0.3×	102 0.5×	111 0.5×	32 0.2×	59	586
Maria P. Mogavero Italy	18	435 1.5×	311 1.1×	168 0.8×	169 0.8×	44 0.3×	75	959
Sebastian C. Holst Switzerland	17	401 1.4×	256 0.9×	190 0.9×	98 0.5×	14 0.1×	28	907

Countries citing papers authored by Rob Zuiker

Since Specialization

Citations

This map shows the geographic impact of Rob Zuiker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Zuiker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Zuiker more than expected).

Fields of papers citing papers by Rob Zuiker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Zuiker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Zuiker. The network helps show where Rob Zuiker may publish in the future.

Co-authorship network of co-authors of Rob Zuiker

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Zuiker. A scholar is included among the top collaborators of Rob Zuiker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Zuiker. Rob Zuiker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zuiker, Rob, Christopher Bryan, Nancy L. Stewart, et al.. (2025). Safety, Pharmacokinetics, and Pharmacodynamics of a 6‐h N,N‐Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled Trial. Clinical and Translational Science. 18(5). e70234–e70234. 1 indexed citations

Sluijs, Pleuntje J. van der, Matthijs D. Kruizinga, Agnies M. van Eeghen, et al.. (2024). Clonazepam repurposing in ARID1B patients through conventional RCT and N-of-1 trials: an experimental strategy for orphan disease development. Journal of Medical Genetics. 62(3). 210–218. 1 indexed citations

Zuiker, Rob, et al.. (2024). Nighttime safety of daridorexant: Evaluation of responsiveness to an external noise stimulus, postural stability, walking, and cognitive function. Journal of Psychopharmacology. 39(3). 223–232. 1 indexed citations

Zuiker, Rob, Jules A. A. C. Heuberger, Marieke de Kam, et al.. (2023). Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations. British Journal of Clinical Pharmacology. 90(1). 321–335.

O’Donnell, Patricio, Erica S. Klaassen, Derek L. Buhl, et al.. (2022). Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers. Translational Psychiatry. 12(1). 408–408. 17 indexed citations

Aart, Jasper van der, Gabriël E. Jacobs, Marieke de Kam, et al.. (2020). Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial. Journal of Psychopharmacology. 34(9). 1030–1042. 44 indexed citations

Salvadore, Giacomo, Pascal Bonaventure, Anantha Shekhar, et al.. (2020). Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans. Translational Psychiatry. 10(1). 308–308. 31 indexed citations

Berger, Benjamin, et al.. (2020). Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects. CNS Drugs. 34(12). 1253–1266. 15 indexed citations

Kruizinga, Matthijs D., Rob Zuiker, Marieke L. de Kam, et al.. (2020). Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B. Neurotherapeutics. 17(3). 1300–1310. 10 indexed citations

10.

Doll, Robert J., et al.. (2020). The use of machine learning improves the assessment of drug-induced driving behaviour. Accident Analysis & Prevention. 148. 105822–105822. 4 indexed citations

11.

Zuiker, Rob, et al.. (2019). Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol. Journal of Psychopharmacology. 33(7). 791–800. 14 indexed citations

12.

Muehlan, Clemens, et al.. (2019). Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration. European Neuropsychopharmacology. 29(7). 847–857. 49 indexed citations

13.

Boer, Peter de, Rob Zuiker, R. Luthringer, et al.. (2019). The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational Psychiatry. 9(1). 216–216. 65 indexed citations

14.

Loo, Aurora J.A.E. van de, Johan Garssen, Rob Zuiker, et al.. (2017). The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study. Psychopharmacology. 234(21). 3175–3183. 22 indexed citations

15.

Schrier, Lenneke, Rob Zuiker, F.W.H.M. Merkus, et al.. (2016). Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation. British Journal of Clinical Pharmacology. 83(4). 721–731. 15 indexed citations

16.

Zuiker, Rob, Ingrid M. C. Kamerling, César A. Calderón, et al.. (2015). Reproducibility of biomarkers in induced sputum and in serum from chronic smokers. Pulmonary Pharmacology & Therapeutics. 33. 81–86. 1 indexed citations

17.

Diamant, Zuzana, Patricia N. Sidharta, Dave Singh, et al.. (2014). Setipiprant, a selective CRTH2 antagonist, reduces allergen‐induced airway responses in allergic asthmatics. Clinical & Experimental Allergy. 44(8). 1044–1052. 68 indexed citations

18.

Diamant, Zuzana, Katharine H. Banner, Rob Zuiker, et al.. (2013). Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. The Lancet Respiratory Medicine. 1(9). 714–727. 134 indexed citations

19.

Zuiker, Rob, et al.. (2011). The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men. Clinical Therapeutics. 33(10). 1492–502. 15 indexed citations

20.

Zuiker, Rob, J. D. Boot, César A. Calderón, et al.. (2010). Sputum induction with hypertonic saline reduces fractional exhaled nitric oxide in chronic smokers and non-smokers. Respiratory Medicine. 104(6). 917–920. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact